NO962294L - Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propylÅ-1-cyklopentylkarbonyl)-tyrosin - Google Patents

Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propylÅ-1-cyklopentylkarbonyl)-tyrosin

Info

Publication number: NO962294L
Authority: NO; Norway
Prior art keywords: polymorphic form; crystalline; mesyllysylamino; cyclopentylcarbonyl; tyrosine
Prior art date: 1993-12-04

Application number

NO962294A

Other languages

English (en)

Other versions

NO306714B1 (no

NO962294D0 (no

Inventor

Peter James Dunn

Michael Leslie Hughes

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-04

Filing date

1996-06-04

Publication date

1996-06-04

1996-06-04 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

1996-06-04 Publication of NO962294L publication Critical patent/NO962294L/no

1996-06-04 Publication of NO962294D0 publication Critical patent/NO962294D0/no

1999-12-13 Publication of NO306714B1 publication Critical patent/NO306714B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Pyrrole Compounds (AREA)

NO962294A 1993-12-04 1996-06-04 Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin NO306714B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939324931A GB9324931D0 (en)	1993-12-04	1993-12-04	Glutaramide derivatives
PCT/EP1994/003750 WO1995015308A1 (en)	1993-12-04	1994-11-09	Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine

Publications (3)

Publication Number	Publication Date
NO962294L true NO962294L (no)	1996-06-04
NO962294D0 NO962294D0 (no)	1996-06-04
NO306714B1 NO306714B1 (no)	1999-12-13

Family

ID=10746163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO962294A NO306714B1 (no)	1993-12-04	1996-06-04	Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin

Country Status (26)

Country	Link
US (1)	US6180665B1 (no)
EP (1)	EP0731787B1 (no)
JP (1)	JP2701988B2 (no)
KR (1)	KR100203314B1 (no)
CN (1)	CN1068586C (no)
AT (1)	ATE175664T1 (no)
CA (1)	CA2178085C (no)
CZ (1)	CZ296428B6 (no)
DE (1)	DE69416003T2 (no)
DK (1)	DK0731787T3 (no)
EG (1)	EG20562A (no)
ES (1)	ES2128031T3 (no)
FI (1)	FI120305B (no)
GB (1)	GB9324931D0 (no)
GR (1)	GR3029590T3 (no)
HU (1)	HU225959B1 (no)
IL (1)	IL111791A (no)
MY (1)	MY115430A (no)
NO (1)	NO306714B1 (no)
NZ (1)	NZ276087A (no)
PE (1)	PE9296A1 (no)
PL (1)	PL178559B1 (no)
RU (1)	RU2131869C1 (no)
TW (2)	TW534901B (no)
WO (1)	WO1995015308A1 (no)
ZA (1)	ZA949595B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7004344B2 (en)	2000-08-29	2006-02-28	Tolko Industries Ltd.	Collapsible bin
FR2824477B1 (fr) *	2001-05-09	2005-09-09	Ethypharm Lab Prod Ethiques	Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
US6975515B2 (en)	2001-08-15	2005-12-13	Agilent Technologies, Inc.	Electrical module
DE202004021379U1 (de) *	2003-02-12	2008-02-21	Ciba Specialty Chemicals Holding Inc.	Kristalline Formen von Pitivastatin Calcium
WO2005123702A1 (en) *	2004-06-15	2005-12-29	Pfizer Limited	Neutral endopeptidase inhibitor polymorph
CN109350736A (zh) *	2018-09-20	2019-02-19	南通大学	防治运动病、梅尼埃病的药物及心房钠尿肽的医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8820844D0 (en) *	1988-09-05	1988-10-05	Pfizer Ltd	Therapeutic agents
US5208236A (en)	1992-09-23	1993-05-04	Schering Corporation	N-(acylaminomethyl)glutaryl amino acids and use

1993
- 1993-12-04 GB GB939324931A patent/GB9324931D0/en active Pending
1994
- 1994-11-07 TW TW089110999A patent/TW534901B/zh not_active IP Right Cessation
- 1994-11-07 TW TW083110283A patent/TW434210B/zh not_active IP Right Cessation
- 1994-11-09 CA CA002178085A patent/CA2178085C/en not_active Expired - Fee Related
- 1994-11-09 CN CN94194942A patent/CN1068586C/zh not_active Expired - Fee Related
- 1994-11-09 WO PCT/EP1994/003750 patent/WO1995015308A1/en active IP Right Grant
- 1994-11-09 DK DK95900719T patent/DK0731787T3/da active
- 1994-11-09 RU RU96115251A patent/RU2131869C1/ru not_active IP Right Cessation
- 1994-11-09 NZ NZ276087A patent/NZ276087A/en not_active IP Right Cessation
- 1994-11-09 CZ CZ0160496A patent/CZ296428B6/cs not_active IP Right Cessation
- 1994-11-09 PL PL94314794A patent/PL178559B1/pl not_active IP Right Cessation
- 1994-11-09 US US08/648,001 patent/US6180665B1/en not_active Expired - Fee Related
- 1994-11-09 EP EP95900719A patent/EP0731787B1/en not_active Expired - Lifetime
- 1994-11-09 ES ES95900719T patent/ES2128031T3/es not_active Expired - Lifetime
- 1994-11-09 DE DE69416003T patent/DE69416003T2/de not_active Expired - Lifetime
- 1994-11-09 AT AT95900719T patent/ATE175664T1/de not_active IP Right Cessation
- 1994-11-09 KR KR1019960702912A patent/KR100203314B1/ko not_active IP Right Cessation
- 1994-11-09 JP JP7515356A patent/JP2701988B2/ja not_active Expired - Fee Related
- 1994-11-09 HU HU9601506A patent/HU225959B1/hu not_active IP Right Cessation
- 1994-11-28 PE PE1994255868A patent/PE9296A1/es not_active Application Discontinuation
- 1994-11-28 IL IL11179194A patent/IL111791A/en not_active IP Right Cessation
- 1994-11-29 MY MYPI94003169A patent/MY115430A/en unknown
- 1994-12-01 EG EG75294A patent/EG20562A/xx active
- 1994-12-02 ZA ZA949595A patent/ZA949595B/xx unknown
1996
- 1996-06-03 FI FI962322A patent/FI120305B/fi not_active IP Right Cessation
- 1996-06-04 NO NO962294A patent/NO306714B1/no not_active IP Right Cessation
1999
- 1999-03-05 GR GR990400677T patent/GR3029590T3/el unknown

Also Published As

Publication number	Publication date
CN1068586C (zh)	2001-07-18
FI962322A0 (fi)	1996-06-03
WO1995015308A1 (en)	1995-06-08
GR3029590T3 (en)	1999-06-30
HU225959B1 (en)	2008-01-28
KR960706470A (ko)	1996-12-09
CZ160496A3 (en)	1996-11-13
RU2131869C1 (ru)	1999-06-20
CA2178085A1 (en)	1995-06-08
DE69416003T2 (de)	1999-05-27
DK0731787T3 (da)	1999-08-30
MY115430A (en)	2003-06-30
ES2128031T3 (es)	1999-05-01
GB9324931D0 (en)	1994-01-26
NO306714B1 (no)	1999-12-13
PL178559B1 (pl)	2000-05-31
JPH09500654A (ja)	1997-01-21
HUT74683A (en)	1997-01-28
ATE175664T1 (de)	1999-01-15
NZ276087A (en)	1997-11-24
IL111791A (en)	2002-09-12
ZA949595B (en)	1996-06-03
FI120305B (fi)	2009-09-15
AU684114B2 (en)	1997-12-04
TW434210B (en)	2001-05-16
KR100203314B1 (ko)	1999-06-15
FI962322A (fi)	1996-06-03
EP0731787A1 (en)	1996-09-18
HU9601506D0 (en)	1996-07-29
IL111791A0 (en)	1995-01-24
PE9296A1 (es)	1996-04-04
DE69416003D1 (en)	1999-02-25
EP0731787B1 (en)	1999-01-13
CN1142816A (zh)	1997-02-12
AU8142494A (en)	1995-06-19
CZ296428B6 (cs)	2006-03-15
PL314794A1 (en)	1996-09-30
EG20562A (en)	1999-08-30
NO962294D0 (no)	1996-06-04
US6180665B1 (en)	2001-01-30
TW534901B (en)	2003-06-01
CA2178085C (en)	2002-09-03
JP2701988B2 (ja)	1998-01-21

Publication	Publication Date	Title
YU34896A (sh)	1999-09-27	Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
FI932229A0 (fi)	1993-05-17	Azabicykliska bryggderivat
BG103485A (en)	2000-01-31	Ketobanzamides as calpain inhibitors
DE69729583D1 (de)	2004-07-22	N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
ES2132415T3 (es)	1999-08-16	Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
CA2318349A1 (en)	1999-07-08	Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
EA200400815A1 (ru)	2004-12-30	Контролируемый синтез зипразидона и его композиции
NZ279397A (en)	1997-08-22	Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
EA200200510A1 (ru)	2002-10-31	4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
FI942457A0 (fi)	1994-05-26	Substituoitujen piperidiinien valmistus
NZ331875A (en)	2000-01-28	Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
NO306714B1 (no)	1999-12-13	Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin
FI963168A (fi)	1996-08-13	Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
IL138638A0 (en)	2001-10-31	Processes for preparing intermediates
DE69827614D1 (de)	2004-12-23	Chinoxalindionen
HUP0204009A2 (hu)	2003-03-28	1. típusú nátrium-hidrogén csere (NHE-1) gátló kristályok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2171972A1 (en)	1995-03-23	Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds

Legal Events

Date	Code	Title	Description
2011-06-27	MM1K	Lapsed by not paying the annual fees